Article
Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment Response
2020-12-21
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>N6-methyladenosine (m6A) modification plays an essential role in diverse key biological processes and may take part in the development and progression of hepatocellular carcinoma (HCC). Here, we systematically analyzed expression profiles and prognostic values of 13 widely reported m6A modification related genes in HCC.<bold>Methods</bold>: mRNA expression of 13...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 99937bf3-206e-50ed-a786-c1940111215d
- DOI
- 10.21203/rs.3.rs-130710/v1
